The new gene therapy is delivered to the placenta by a polymer nanoparticle so small it would take roughly 500 of them, side by side, to equal the width of a human hair. The nanoparticle carries ...

Compared to viral methods commonly used for gene therapy, these DNA-LNPs can carry ... Patel et al, Safer non-viral DNA delivery using lipid nanoparticles loaded with endogenous anti-inflammatory ...

Verve Therapeutics said Monday that initial data show that its investigational gene-editing therapy lowered cholesterol ...

Glioblastoma multiforme is an aggressive brain tumor that mainly affects adults. Approximately 30,000 people in the U.S. are ...

Wall Street analysts said the results for Verve’s therapy appeared competitive on efficacy, while avoiding any major safety ...

The global gene therapy market is projected to grow at a significant CAGR of 20% from 2024 to 2029. This growth is driven by ...

Cancer Gene Therapy Market Breast and Lung Cancer dominate, driven by high incidence and genetic testing integration. US, NY, UNITED ST ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy for oncologists treating patients in a community setting.

Feb. 7, 2025 — A research team has made a major discovery on how the CUL5 gene affects CAR-T cell therapy, an advanced cancer therapy. The study reveals that reducing the activity of the CUL5 ...

Compared to viral methods commonly used for gene therapy, these DNA-LNPs can carry larger genetic ... Safer non-viral DNA delivery using lipid nanoparticles loaded with endogenous anti-inflammatory ...